These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8259469)

  • 1. [Restless legs syndrome. Report of experience].
    Grandjean P
    Schweiz Rundsch Med Prax; 1993 Oct; 82(43):1195-7. PubMed ID: 8259469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Six months treatment of restless legs syndrome with levodopa/benserazide in domiciliary practice].
    Mühlau G
    MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):87-93. PubMed ID: 15662897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome?
    Trenkwalder C; Collado Seidel V; Kazenwadel J; Wetter TC; Oertel W; Selzer R; Kohnen R
    Mov Disord; 2003 Oct; 18(10):1184-9. PubMed ID: 14534925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of idiopathic and uremic restless legs syndrome with L-dopa--a double-blind cross-over study].
    Wetter TC; Trenkwalder C; Stiasny K; Pollmächer T; Kazenwadel J; Kohnen R; Künzel M; Oertel WH
    Wien Med Wochenschr; 1995; 145(17-18):525-7. PubMed ID: 8588396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Restless legs syndrome: therapeutic possibilities in the medical practice].
    Bachmann CG; Trenkwalder C
    MMW Fortschr Med; 2005 May; 147 Spec No 2():44-7. PubMed ID: 15968872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease].
    Eichhorn TE; Schrag A; Trenkwalder C; Selzer R; Kohnen R; Oertel WH; Poewe W
    Nervenarzt; 1995 Dec; 66(12):933-41. PubMed ID: 8584079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome.
    Garcia-Borreguero D; Larrosa O; Granizo JJ; de la Llave Y; Hening WA
    Sleep; 2004 Jun; 27(4):669-73. PubMed ID: 15283001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What helps in the treatment of restless legs?].
    Mühlau G
    MMW Fortschr Med; 2004 Nov; 146(46):49. PubMed ID: 15600046
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of idiopathic and uremic restless legs syndrome].
    Trenkwalder C; Stiasny K; Oertel WH
    Nervenarzt; 1996 Apr; 67(4):265-76. PubMed ID: 8684504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome.
    Vetrugno R; Contin M; Baruzzi A; Provini F; Plazzi G; Montagna P
    Mov Disord; 2006 Feb; 21(2):254-8. PubMed ID: 16200540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.
    García-Borreguero D; Kohnen R; Högl B; Ferini-Strambi L; Hadjigeorgiou GM; Hornyak M; de Weerd AW; Happe S; Stiasny-Kolster K; Gschliesser V; Egatz R; Cabrero B; Frauscher B; Trenkwalder C; Hening WA; Allen RP
    Sleep Med; 2007 Aug; 8(5):455-63. PubMed ID: 17543579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restless legs syndrome.
    Bayard M; Avonda T; Wadzinski J
    Am Fam Physician; 2008 Jul; 78(2):235-40. PubMed ID: 18697508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [When L-Dopa preparations, dopamine agonists or opioids? Therapy of restless legs syndrome].
    Tings T; Trenkwalder C
    MMW Fortschr Med; 2003 Mar; 145(10):48-9. PubMed ID: 12688028
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.
    Evans AH; Butzkueven H
    Mov Disord; 2007 Mar; 22(4):590-1. PubMed ID: 17230484
    [No Abstract]   [Full Text] [Related]  

  • 15. Validation of the "L-DOPA test" for diagnosis of restless legs syndrome.
    Stiasny-Kolster K; Kohnen R; Möller JC; Trenkwalder C; Oertel WH
    Mov Disord; 2006 Sep; 21(9):1333-9. PubMed ID: 16705685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of restless legs syndrome with levodopa plus benserazide.
    Akpinar S
    Arch Neurol; 1982 Nov; 39(11):739. PubMed ID: 7126008
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of restless leg syndrome with pergolide--an open clinical trial.
    Winkelmann J; Wetter TC; Stiasny K; Oertel WH; Trenkwalder C
    Mov Disord; 1998 May; 13(3):566-9. PubMed ID: 9613756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS; Kushida CA
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Restless legs, restless nights: therapeutic options in RLS].
    Kassubek J; Unrath A
    MMW Fortschr Med; 2009 Mar; 151(13):65-7, 69. PubMed ID: 19504823
    [No Abstract]   [Full Text] [Related]  

  • 20. [Restless legs syndrome. Diagnosis and therapy].
    Stiasny K; Oertel WH
    MMW Fortschr Med; 2000 Oct; 142(41):46-8. PubMed ID: 11085078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.